Showing results (1011-1020 of 3,965) with videos related to
Sort By:
Pageof 397
Translational Cancer Research|April 15, 2024
Low expression of KLRB1 predicts poor survival outcomes and is associated with immune infiltration in breast cancerXiao Liu, Qianqian Cui, Nan QinTranslational Cancer Research|April 15, 2024
A pyroptosis-related lncRNA-based prognostic index for hepatocellular carcinoma by relative expression orderingsJinhua Tan, Xiaoqing YuTranslational Cancer Research|July 15, 2022
Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastasesTing Wang, Chuan Liu, Wancong Wang, et al.Translational Cancer Research|July 15, 2022
Diagnostic value of objective VELscope fluorescence methods in distinguishing oral cancer from oral potentially malignant disorders (OPMDs)Caijiao Wang, Xiangmin Qi, Xiaofang Zhou, et al.Translational Cancer Research|July 15, 2022
Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategyMin Wei, Xuefei Bai, Qiaomei DongTranslational Cancer Research|July 15, 2022
miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expressionZhenzhen Wang, Xintao Jing, Fang Li, et al.Translational Cancer Research|July 15, 2022
Hesperetin ameliorates glioblastoma by inhibiting proliferation, inducing apoptosis, and suppressing metastasisQian Cheng, Lianzhi Mao, Hongxiang Huang, et al.Translational Cancer Research|July 15, 2022
Screening diagnostic markers for acute myeloid leukemia based on bioinformatics analysisWenting Chen, Dan Liu, Guyun Wang, et al.Translational Cancer Research|April 14, 2025
Diagnostic test of conventional ultrasonography combined with contrast-enhanced ultrasound in the subcategorization of suspicious Breast Imaging-Reporting and Data System (BI-RADS) 4 breast lesionsYindi Zhu, Dian Zhang, Xiao-Na Wang, et al.Translational Cancer Research|April 14, 2025
A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in EGFR-mutated MET-amplified non-small cell lung cancerJi Yeon Song, Hyunsook An, Soojeong KimPageof 397